Database

Startups

Main Industry
Biotechnology
Main Product/Service
Neurology
Pipeline
Utilizing Yoda’s proprietary AI-based drug screening platform, we engage in the exploration and development of promising and beneficial products to address unmet medical needs, instilling new hope in patients.YA-101 Multiple System Atro
Founded Year
2022
Unified Business No.
89116715
Status
Active
Number of Employees
0
Total Paid-in Capital
773,881,600 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Introduction
Yoda Pharmaceuticals Inc. was founded in 2019 through a collaboration of researchers from National Taiwan University, National Yang Ming Chiao Tung University, and the National Health Research Institutes, along with psychiatric physicians in practice. Inc



More2 ↓

Similar Companies

ALAR PHARMACEUTICALS INC.

Different from the current long-acting technologies, drug products developed by our unique long-acting release platform (In-Relar) have distinctive characteristics such as low viscosity solution, small injection volume, and sustained drug release profile,

SyneuRx International (Taiwan) Corp.

SyneuRx proudly presents three mental health products: NEUDAMENS® Memo, NEUDAMENS® Mood, and NEUDAMENS® Sleep-In.

These products stand apart from conventional supplements by featuring NEUDAMENS®, a proprietary active ingredient developed through years of

ChemAI Co., Ltd.

Solutions -
1. ADDD platform
2. VIRTUALMAN for ADMET/PK
3. Customized Al

Insilico Medicine Taiwan Limited

Insilico’s flagship suite includes PandaOmics (multi-omics target identification), Chemistry42 (de novo molecular design), and InClinico (clinical outcome prediction). By leveraging these AI modules, they can rapidly generate novel molecules, predict safe
:::